EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineered bacteriophages for therapeutic and diagnostic applications

Kandas Traore, Damien Seyer, Agnes Mihajlovski iD, Antonia P Sagona iD

Disease Models & Mechanisms · 01.09.2025 · 18 (9)

DOI: 10.1242/dmm.052393 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Disease Models & Mechanisms, online erschienen am 30.09.2025. Verfasst von Kandas Traore und 3 weiteren Autor:innen. Beteiligte Einrichtung: CY Cergy Paris Université, ERRMECe Laboratory, Biomaterials for Health Group, Neuville Sur-Oise 95031, France. Hauptthemen laut MEDLINE: Bacteriophages, Phage Therapy, Genetic Engineering. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Eutopia Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance represents one of the most serious threats to both public health and economic sustainability. One of the promising approaches to address this problem is phage therapy – treatment of pathogenic bacterial infections using bacteriophages. Bacteriophages have a narrow host spectrum of activity, minimal side effects and self-replication at the infection site, which positions them as promising candidates to complement or replace conventional antibiotics. Moreover, they can be easily genetically modified to enhance their effectiveness and safety. In this At a Glance article, we highlight the timely relevance of engineered phages as an innovative solution in a rapidly evolving healthcare landscape. First, we introduce bacteriophages' life cycle, ecology and therapeutic history, emphasizing their role in One Health strategies. Then, we describe advanced engineering techniques that can be used to expand bacteriophages' functionalities. Finally, we discuss innovative applications of engineered bacteriophages in biotechnological applications and as a potential countermeasure for antimicrobial resistance, including serving as a shuttle for delivering genes and drugs to the targeted bacterial and eukaryotic cells, targeting intracellular bacteria, contributing to vaccine development, facilitating advancements in tissue engineering and improving bacteriophages' antibacterial properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriophagesPhage TherapyGenetic EngineeringHumansAnimalsBacterial Infections

Stichwörter der Autor:innen

Antibiotic resistanceBacteriophagesGenomic engineeringNanomedicine

Autor:innen und Institutionen

  • CY Cergy Paris Université, ERRMECe Laboratory, Biomaterials for Health Group, Neuville Sur-Oise 95031, France.
  • School of Life Sciences, Warwick University, Gibbet Hill Campus, Coventry CV4 7AL, UK.

ORCID-Profile: Agnes Mihajlovski, Antonia P Sagona

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Eutopia Foundation

Zitieren

APA

Traore, K., Seyer, D., Mihajlovski, A., & Sagona, A. P. (2025). Engineered bacteriophages for therapeutic and diagnostic applications. Disease Models & Mechanisms, 18(9). https://doi.org/10.1242/dmm.052393

Vancouver

Traore K, Seyer D, Mihajlovski A, Sagona AP. Engineered bacteriophages for therapeutic and diagnostic applications. Disease Models & Mechanisms. 2025;18(9). doi:10.1242/dmm.052393

BibTeX
@article{Traore2025,
  author = {Traore, Kandas and Seyer, Damien and Mihajlovski, Agnes and Sagona, Antonia P},
  title = {Engineered bacteriophages for therapeutic and diagnostic applications},
  journal = {Disease Models & Mechanisms},
  year = {2025},
  volume = {18},
  number = {9},
  doi = {10.1242/dmm.052393}
}
Kostenlos starten →